Allogene Therapeutics, Inc. (ALLO) — DEF 14A Filings
All DEF 14A filings from Allogene Therapeutics, Inc.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
Allogene Therapeutics Sets June 5th Virtual Annual Meeting
— Apr 23, 2024 Risk: low
Allogene Therapeutics, Inc. will hold its 2024 Annual Meeting of Stockholders on June 5, 2024, at 8:00 a.m. Pacific Time. The meeting will be a virtual event wh
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX